Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
Completed · Phase 3
Conditions studied: Secondary Hypogonadism
In brief
Subjects who completed ZA-003 were eligible to receive an additional year of treatment in this extension study.
Key facts
- Study ID
- NCT01067365
- Run by
- Repros Therapeutics Inc.
- People needed
- 104
- Starts
- 2006-03-01
- Expected to finish
- 2007-05-01
- Last updated by the study team
- 2014-06-27
Who can join
Age: 18 and older, up to 68. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Total serum testosterone concentrations < 300 ng/dL at baseline
You may not qualify if…
- Presence or history of prostate cancer
- Elevated PSA > 3.5 ng/mL
- Additional inclusion and exclusion criteria may apply.
Where it is running
- Alabama Clinical Therapeutics, LLC — Birmingham, Alabama, United States
- Medial Affiliated Research Center, Inc. — Huntsville, Alabama, United States
- Northern California Research Corp — Carmichael, California, United States
- Prime-Care Clinical Research — Mission Viejo, California, United States
- Harbor-UCLA Medical Center — Torrance, California, United States
- Chase Medical Research, LLC — Waterbury, Connecticut, United States
- Southeastern Research Group, Inc. — Tallahassee, Florida, United States
- Northeast Indiana Research, LLC — Fort Wayne, Indiana, United States
- Commonweatlh Biomedical Research — Madisonville, Kentucky, United States
- The Center for Sexual Medicine at Sheppard Pratt — Baltimore, Maryland, United States
- Office of Keith Pierce, MD — Livonia, Michigan, United States
- Office of Michael Mall, MD — Las Vegas, Nevada, United States
- Office of Stephen Miller, MD — Las Vegas, Nevada, United States
- Advanced Biomedical Research, Inc. — Hackensack, New Jersey, United States
- Office of Gary S. Karlin, MD — Lawrenceville, New Jersey, United States
- Medical Research Associates of Nashville — Nashville, Tennessee, United States
- Urology San Antonio Research, PA — San Antonio, Texas, United States
- Salt Lake Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.